Delivery Order SPE2DB22D1106-SPE2DB25FEBV2

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 MCG Inhaler 12GM. The contract has a ceiling value of $12,996.79 and runs through February 16, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG Inhaler 12GM. The contract has a ceiling value of $4,650.78 and a completion date of June 7, 2024. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 mcg inhalers. The contract has a ceiling value of $1,692.03 and a completion date of January 2, 2025. It is a firm-fixed-price contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,848.24 and a completion date of January 5, 2024. It is a firm fixed-price contract for the delivery of Advair HFA 115-21 mcg inhalers. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 mcg Inhaler (12 gm). The contract has a ceiling value of $1,561.98 and an ultimate completion date of August 2, 2024. It is a firm-fixed price contract with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a ceiling value of $4,494.12 and runs through February 18, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 mcg inhalers. The contract has a firm fixed price of $4,642.51 and an ultimate completion date of August 7, 2024. AmerisourceBergen has been awarded this contract as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 MCG inhalers, with a ceiling value of $4,856.38 and a period of performance through August 27, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 45-21 MCG INHALER 12GM. The contract has a ceiling value of $5,708.49 and a completion date of January 4, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a firm fixed price of $2,403.52 and a completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEBV2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 MCG Inhaler 12GM. The contract has a ceiling value of $1,562.60 and runs through March 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/5/25, 10:14 AM